In correlation with these, TAC tends to increase tumorigenic mTORC1/C2 activation and promotes proliferation in a cell-type dependent manner in epithelial and RCC cell lines, induced ischaemic kidneys, and RCC xenograft tumours as well. The gene discussed is C2; the disease is renal cell carcinoma.